Corticosteroids and Mesalamine Versus Corticosteroids for Acute Severe Ulcerative Colitis: A Randomized Controlled Trial

This publication has 18 references indexed in Scilit:

• Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
  Journal of Crohn's and Colitis, 2017
• Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission
  Digestive Diseases and Sciences, 2015
• Intravenous corticosteroids in moderately active ulcerative colitis refractory to oral corticosteroids
  Journal of Crohn's and Colitis, 2014
• Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
  The Lancet, 2012
• Response to Corticosteroids in Severe Ulcerative Colitis: A Systematic Review of the Literature and a Meta-Regression
  Clinical Gastroenterology and Hepatology, 2007
• The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients
  Alimentary Pharmacology & Therapeutics, 2005
• Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial management, data analysis, and writing the paper. Maja Noman had a major contribution in the clinical ambulatory follow-up of the patients in the trial. Martin Hiele followed cyclosporine levels and adjusted drug doses of patients in the trial and provided statistical advice. Katrien Asnong was the study coordinator and had a major share in data analysis. Joris Arts analyzed safety data and followed patients clinically during the trial. Andre D’Hoore and Freddy Penninckx performed the surgical interventions in patients failing the trial and substantially contributed in evaluating patients for colectomy.
  Gastroenterology, 2003
• Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis
  Gastroenterology, 2001
• Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy
  New England Journal of Medicine, 1994
• Cortisone in Ulcerative Colitis
  BMJ, 1955